generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …

-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel … regulation in lowering drug prices, while the cross-price effect raises a concern about patent protection. …

We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical … (of illness), but rely on information to prescribe the correct drug. Drug information is conveyed by marketing (detailing …

the profits are sufficient to cover the entry costs. The other brand-name drug has already lost its patent and faces … strongest under TRP, resulting in the lowest drug prices (and medical expenditures). However, TRP also provides the lowest … profits to the patent-holding firm, making entry of the new drug treatment least likely. Surprisingly, we find that GRP …